Pharmacia Articles
Chiron adds two senior VPs to BioPharma unit
7 July 2003
French drug industry body names new board members
30 June 2003
Stock Commentary - New York
23 June 2003
Pfizer to downsize Japanese operations
23 June 2003
Pfizer reins in 2003 forecast, raises 2004
23 June 2003
Janssen Japan recruits Carl Taeusch
9 June 2003
Pfizer and Akzo Nobel sign supply deal
9 June 2003
Rating Research upgrades Pfizer
9 June 2003
Yamanouchi's FY2003 operating income up 12%
26 May 2003
Vicuron continues Pfizer collaboration
19 May 2003
Pfizer Thailand sees slow growth 'til 2005
19 May 2003
Pfizer announces expansions in NY and NJ
12 May 2003
Pfizer to close five units following merger
5 May 2003
Stock Commentary - New York
5 May 2003
Indevus files for OAB drug trospium in USA
5 May 2003
Colorado Medicaid sets eight-drug limit
5 May 2003
Goran Ando becomes Celltech CEO
28 April 2003
Hassan takes biggest pay rise in 2002 CEO compensation
28 April 2003
Galen completes Pfizer product acquisitions
28 April 2003
Almirall licenses triptan to Ortho-McNeil
28 April 2003
Pfizer expands patient assistance program
21 April 2003
Fred Hassan not to join Pfizer/Pharmacia board
21 April 2003
Stock Commentary - New York
21 April 2003
Yakult Honsha tips 68% leap in profits
21 April 2003
NZ clears Pfizer/Pharmacia merger
14 April 2003
ProEthic transdermal ketoprofen deal
14 April 2003
Stock Commentary - New York
31 March 2003
Stock Commentary - Europe
31 March 2003
Further progress for Pfizer/Pharmacia deal
31 March 2003
Forest Labs is BusinessWeek 50's top-performing company
31 March 2003
Canadian pharmacy to open 360 US units
31 March 2003
Stock Commentary - Europe
24 March 2003
Connecticut sues seven drugmakers
24 March 2003
NeoPharm's losses grow in 4th-qtr
24 March 2003
$36B women's Rx drug market to double by 2008
24 March 2003
Pfizer merger oked by EC but not without cost
10 March 2003
Stock Commentary - Europe
10 March 2003
Stock Commentary - New York
10 March 2003
Pfizer/Pharmacia merger clears EU hurdle
3 March 2003
Watson's incontinence patch cleared by US FDA
3 March 2003
First launch, in Canada, for AstraZeneca's superstatin Crestor
24 February 2003
NY claims of Rx overcharging could lead to industry-wide probe
24 February 2003
Update: Pharmacia's earnings match forecasts in 2002
24 February 2003
Pharmacia's earnings match forecasts in 2002
24 February 2003
Update: Blow to Orion as deramciclane fails
24 February 2003
SangStat, Abgenix drop GVHD drug
24 February 2003
Blow to Orion as deramciclane fails in Phase III anxiety studies
24 February 2003
Caraco expects $35M revenues in 2003
24 February 2003
Celltech set to spoil OGS/CAT merger?
24 February 2003
Italian prosecutors probe GlaxoSmithKline's marketing practices
24 February 2003
CAT'S shares fall on OGS merger
17 February 2003
2002's crop of new product launches backs up R&D fears
10 February 2003
New report sees big changes for global antibiotics market
10 February 2003
Pharmacia pilots plan for Rescriptor in LDCs
3 February 2003
Pharmacia, Pfizer merger provides ED windfall for Nastech
3 February 2003
Pharmacia grants access to HIV drug
3 February 2003
Stock Commentary - week to Jan 20 - New York
27 January 2003
Stock Commentary - week to Jan 20 - Europe
27 January 2003
53.7% US sales leap boosts Sanofi-Synthelabo
27 January 2003
Drugmakers' success depends on effective therapeutic franchising
27 January 2003
Effect of Merck & Co Banyu buy assessed
27 January 2003
Biovitrum deal with Lundbeck for protein therapeutic production
20 January 2003
Yamanouchi files in USA for incontinence drug
13 January 2003
Round-up of pharmaceutical mergers and acquisitions during 2001
13 January 2003
Dr Reddy's first own-label brand in USA
13 January 2003
Xalatan gets first-line approval in USA
6 January 2003
Millennium starts Ph II Velcade trial in CRC
6 January 2003
New York Stock Commentary - 2 weeks to Dec 30
6 January 2003
Celebrex as good as two drugs for ulcers
6 January 2003
Tokyo pharma stocks - 2 weeks to Dec 30
6 January 2003
Hassan seeks freedom assurances from S-P
6 January 2003
Pharmacia's Inspra meets EPHESUS primary endpoints
6 January 2003
Pharmacia, Yamanouchi file celecoxib in Japan
6 January 2003
Eloxatin gets approval in key US market - updated story
19 August 2002
Eloxatin cleared in USA for colorectal cancer
19 August 2002
Pharmacia sets Monsanto share allocation
12 August 2002
Celltech acquires Pharmacia's Dipentum
5 August 2002
NeoGenesis signs discovery accord with Pharmacia
5 August 2002
10 most effective US DTC television ads
5 August 2002
Pharmacia/Pfizer welcome CPMP move
5 August 2002
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
